Medline Inc. is a provider of medical-surgical products and supply chain solutions serving hospitals, surgery centers, physician offices, and post-acute facilities. Founded in 1966, the company operates through two reportable segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment offers products across Front Line Care, Surgical Solutions, and Laboratory and Diagnostics, including wound care, exam gloves, surgical kits, and diagnostic instruments. The Supply Chain Solutions segment distributes products from third-party suppliers and provides services such as consulting, outsourced warehouse management, and third-party logistics. Medline utilizes a Prime Vendor model to act as a consolidated logistics partner for customers, supported by a global distribution network and an owned fleet of MedTrans trucks. The company serves customers in the United States and international markets, leveraging artificial intelligence and robotics in its distribution centers to optimize logistics.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Distribution Homepage ir.medline.com
Sector Healthcare IR page newsroom.medline.com
Tags
medical-surgical products, supply chain solutions, wound care, surgical supplies, diagnostics, prime vendor, third-party logistics, incontinence care, laboratory consumables, distribution network, Medline Brand, MedTrans, Front Line Care, Surgical Solutions, Laboratory and Diagnostics
Press page —

Metrics

Valuation  
Market cap $ 46.272B
Market cap (USD) $ 46.272B
P/E 39.92
PEG —
P/BV 3.92
P/S 1.63
P/OCF 26.53
P/FCF 35.68
Dividend yield —
Turnover / mcap —
Returns  
ROE 10.8%
ROI 5.0%
ROIC 8.8%
Profit margin 4.1%
Growth  
Revenue growing —
Profits growing —
Revenue up 3y —
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding —
Buying back stock —
Diluting (TTM) —
Debt/Equity 106.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 18
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025
Revenue 28.432B
Net profit 1.159B
Free cash flow 1.297B

Figure FY 2025
Share price 42
P/FCF 42.55

Filed figures

Figure Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 3.22B 3.53B
↳ YoY growth +9.8%
Borrowings, current (USD) — — 78M 77M
Borrowings, non-current (USD) — — 16.4B 12.5B
Lease liabilities (USD) — — 405M 452M
Cash and deposits (USD) 399M 1.59B 199M 1.94B
Intangible assets (USD) — — 14.6B 13.9B
Right-of-use assets (USD) — — 384M 432M
Net debt (borrowings + leases - cash) (USD) — — 16.7B 11.1B
Cash flow detail
Operating cash flow (USD) — 1.69B 1.77B 1.74B
Purchases of property, plant and equipment (USD) — -275M -354M -447M
Change in receivables (cash effect) (USD) — -153M -256M -355M
Change in inventories (cash effect) (USD) — 444M -545M -264M
Change in payables (cash effect) (USD) — 136M 106M 73M
Share buybacks (cash effect) (USD) — 0.00 -20M -33M
Interest paid (cash effect) (USD) — -1.13B -1.02B -944M
Income taxes paid (cash effect) (USD) — -52M -101M -62M
Share-based compensation (USD) — 78M 61M 76M
Operating cash flow before change in receivables (USD) — 1.84B 2.03B 2.1B
Free cash flow (OCF - PPE - intangibles) (USD) — 1.41B 1.42B 1.3B
Income detail
Research and development expense (USD) — 60M 67M 80M
Total comprehensive income (USD) — 160M 1.02B 1.19B
Comprehensive income to owners (USD) — 160M 1.02B 1.19B
Provision for credit losses (USD) — 8M 63M 54M
Credit cost ratio (credit losses / average receivables) (%) — — — 1.6%
Reported Feb 25, 2026 Feb 25, 2026 Feb 25, 2026 Feb 25, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Northfield, Ill., November 17, 2026 (GLOBE NEWSWIRE) – Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of its secondary offering of 60,000,000 shares of Medline’s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC along with GIC Private Limited and its managed affiliate and a wholly owned subsidiary of the Abu Dhabi Investment Authority (collectively, the “Selling Stockholders”) at a price to the public of $35.50 per share (the “Offering”). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Medline’s Class A common stock. The Offering is expected to close on November 23, 2026, subject to customary closing conditions.

Medline is not selling any shares of Class A common stock in the Offering and will not receive any of the proceeds from the sale.

Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities and J.P. Morgan are acting as global coordinators and joint bookrunning managers.

•Third quarter net sales of $7.9 billion, an increase of 10.4%

•Third quarter net income of $318 million, a decrease of 1.2%

•Third quarter Adjusted EBITDA1 of $1.0 billion, an increase of 11.8%

•Nine months net sales of $22.9 billion, an increase of 10.9%

•Nine months net income of $696 million, a decrease of 28.8%

•Nine months Adjusted EBITDA1 of $2.8 billion, an increase of 5.0%

•Raising full year 2026 Organic Sales2 guidance to 10.0% to 10.5% from 9.0% to 10.0% and reaffirming Adjusted EBITDA2 guidance of $3.3 billion to $3.4 billion

•Board of Directors authorized a $1 billion share repurchase program

NORTHFIELD, Ill., Nov. 4, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care3, today reported its operating results for the three and nine months ended September 26, 2026.

“Medline delivered another strong quarter, with double-digit net sales growth, reflecting continued momentum across our business,” said Jim Boyle, chief executive officer of Medline.

Medline announces Prime Vendor agreement with Forum Health Bull 1 Bear 0 Order/contract

Medline announces Prime Vendor agreement with Forum Health

Agreement provides access to Medline’s medical-surgical products and supply chain solution offerings

By Medline Newsroom Staff | October 28, 2026

Northfield, Ill., Oct. 28, 2026 – Medline (Nasdaq: MDLN) today announced it has signed a new Prime Vendor agreement with Forum Health, building on the organizations’ existing relationship. Forum Health is a Michigan-based functional medicine health network that provides individually tailored healthcare to patients nationwide.

Through this agreement, Forum Health will have access to Medline’s comprehensive portfolio of medical-surgical products, including IV therapy, needles and syringes and pharmaceuticals, as well as powerful distribution capabilities to help streamline ordering and timely, reliable delivery of medical supplies.

“Supporting clinics across the country takes a supply partner that can keep up, and Medline has done that for us,” said Lee Fuller, vice president of operations, Forum Health. “Their supply chain gives us the reliability and range of options we need at every location, and buying as a group lets us put our combined volume to work for real cost savings. What stands out most, though, is their service. You learn the most about a partner when something does not go as planned, and Medline has shown up for us every time. As Forum Health continues to grow, we’re glad to have them alongside us.”

Brad Mariam, executive vice president of non-acute care sales, Medline, said, “Forum Health is a true partner, and we’re honored to support their continued growth. Their commitment to delivering exceptional patient care aligns closely with our mission, and we’re proud to provide the supply chain support, savings opportunities and service they need to help them succeed across every location. We look forward to growing together in the years ahead.”

Learn how Medline works with physician office health networks to improve clinical, financial and operational outcomes at https://www.medline.com/about-us/who-we-serve/physician-office/ .

About Medline

Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Ill., the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com .

Prompts

Medline Inc. (ticker MDLN), listed in United States.

ETFs Holding Medline Inc.

ETF Weight in ETF Shares Market value As of
LQAI 1.41% 786 $ 31.424K Nov 12, 2026
CGMM 0.57% 525,479 $ 20.583M Nov 16, 2026
LRGC 0.56% 215,195 $ 7.538M Aug 31, 2026
CGUS 0.56% 1,708,435 $ 66.919M Nov 16, 2026
MFSV 0.46% 79,039 $ 2.769M Aug 31, 2026
FFLG 0.28% 41,873 $ 1.645M Jul 31, 2026
FTLS short -0.20% -132,938 $ 0.00 Nov 16, 2026
BDVL short -0.18% -82,373 $ -3.227M Nov 16, 2026
CLSE short -0.15% -38,607 $ -1.352M Aug 31, 2026
IALT short -0.14% -282,794 $ -11.077M Nov 16, 2026
FBCG 0.11% 187,652 $ 7.371M Jul 31, 2026
MSSM 0.08% 16,609 $ 581.813K Aug 31, 2026
BRHY 0.07% 2,473 $ 96.867K Nov 16, 2026
MODL 0.04% 9,861 $ 388.918K Jun 30, 2026
AVMC 0.02% 2,201 $ 86.213K Nov 16, 2026
APUE 0.01% 8,891 $ 311.452K Aug 31, 2026
AVUS 0.00% 682 $ 26.714K Nov 16, 2026
AVSU 0.00% 45 $ 1,762.65 Nov 16, 2026
AVLC 0.00% 1,591 $ 62.319K Nov 16, 2026